We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Diagnosis and management of thyrotoxicosis.
American Family Physician 1996 September 16
Outcome-oriented clinical studies and comprehensive management guidelines for thyroid disease have recently been published. Thyrotoxicosis is a differential diagnostic challenge, and determining the etiology is the most critical step in management. Thyrotoxicosis is referred to as hyperthyroidism when sustained thyroid hyperfunction results in increased thyroid hormone biosynthesis and release from the gland. The most common cause is Graves' disease, but toxic nodular goiters frequently occur in elderly patients. Less common forms include iodine-induced hyperthyroidism, human chorionic gonadotropin-associated thyrotoxicosis and pituitary resistance to thyroid hormone regulation, in which free thyroxine is elevated in clinically euthyroid or hypothyroid patients but thyroid-stimulating hormone is normal to increased. Nonhyperthyroid thyrotoxic states are associated with low radioactive iodine uptake ratios, as seen in the three types of subacute thyroiditis, ectopic hormone production or exogenous ingestion of thyroid hormone. Management of thyrotoxicosis requires lowering of thyroid levels to maintain a euthyroid state. The patient should actively participate in therapeutic decisions. Antithyroid drugs, radioactive iodine and surgery are the principal forms of treatment. Adjunctive therapy may be indicated in some cases. Prolonged follow-up is necessary in all cases.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app